Variant report
Variant | esv3360587 |
---|---|
Chromosome Location | chr12:66461335-66464633 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs576975189 | chr12:66461360-66461361 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs572964043 | chr12:66461364-66461365 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs545657933 | chr12:66461372-66461373 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs187140633 | chr12:66461392-66461393 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs563184477 | chr12:66461420-66461421 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs191435145 | chr12:66461584-66461585 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs551801823 | chr12:66461633-66461634 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs78214230 | chr12:66461671-66461672 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs527882376 | chr12:66461716-66461717 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs149477561 | chr12:66461728-66461729 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs77453242 | chr12:66461730-66461731 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs575294035 | chr12:66461731-66461732 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs536389593 | chr12:66461739-66461740 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs183644700 | chr12:66461757-66461758 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs569982238 | chr12:66461764-66461765 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs538991491 | chr12:66461780-66461781 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs558914538 | chr12:66461781-66461782 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs190700341 | chr12:66461843-66461844 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs534822910 | chr12:66461859-66461860 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs181987439 | chr12:66461877-66461878 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs12427038 | chr12:66461902-66461903 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs190135345 | chr12:66461945-66461946 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs12826980 | chr12:66461979-66461980 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs12827140 | chr12:66462013-66462014 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs571099863 | chr12:66462017-66462018 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs181815606 | chr12:66462174-66462175 | Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
27 | rs28972359 | chr12:66462183-66462184 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs189940315 | chr12:66462208-66462209 | Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
29 | rs28971927 | chr12:66462217-66462218 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs180889532 | chr12:66462221-66462222 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs28970452 | chr12:66462236-66462237 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs28971679 | chr12:66462237-66462238 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs184958591 | chr12:66462242-66462243 | Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
34 | rs190933805 | chr12:66462243-66462244 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs576784021 | chr12:66462251-66462252 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs551344540 | chr12:66462278-66462279 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs367672663 | chr12:66462282-66462283 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs375407739 | chr12:66462291-66462292 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs370819670 | chr12:66462306-66462307 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs565245837 | chr12:66462308-66462309 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs369133955 | chr12:66462313-66462314 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs373806416 | chr12:66462342-66462343 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs535741992 | chr12:66462371-66462372 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs528015805 | chr12:66462378-66462379 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs547678916 | chr12:66462386-66462387 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs561172128 | chr12:66462403-66462404 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs530296523 | chr12:66462405-66462406 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs184038378 | chr12:66462409-66462410 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs371351343 | chr12:66462412-66462413 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs371275996 | chr12:66462413-66462414 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17899364 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
liposarcomas | 17372913 | CNVD |
Non-small cell lung cancer | 24170126 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21785460 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Cancer | 20164919 | CNVD |
Leukemia | 18628472 | CNVD |
Fibroblasts | 20926602 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Lung cancer | 16773561 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Mental retardation | 17220210 | CNVD |
Osteopoikilosis | 17220210 | CNVD |
short stature | 17220210 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
abnormal development | 18461090 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Breast cancer | 16620391 | CNVD |
Neuroticism | 17667963 | CNVD |
Breast cancer | 21364760 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Breast cancer | 22048815 | CNVD |
Congenital anomalies of the kidney and urinary tract | 21113617 | CNVD |
Glioblastoma multiforme | 22291905 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Lung cancer | 17925434 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Disease | 21505450 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Cancer | 20164920 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:66459400-66461600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
2 | chr12:66460000-66461400 | Flanking Active TSS | GM12878-XiMat | blood |
3 | chr12:66460200-66461400 | Enhancers | Cortex derived primary cultured neurospheres | brain |
4 | chr12:66460800-66461400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
5 | chr12:66460800-66464600 | Weak transcription | Primary monocytes fromperipheralblood | blood |
6 | chr12:66460800-66465200 | Weak transcription | Primary B cells from cord blood | blood |
7 | chr12:66460800-66466000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr12:66461000-66464600 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
9 | chr12:66461200-66464800 | Weak transcription | Primary hematopoietic stem cells | blood |
10 | chr12:66461200-66464800 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
11 | chr12:66461200-66465200 | Weak transcription | Primary B cells from peripheral blood | blood |
12 | chr12:66461400-66464200 | Weak transcription | GM12878-XiMat | blood |
13 | chr12:66461400-66465000 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
14 | chr12:66461600-66465200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
15 | chr12:66464200-66465400 | Enhancers | Ovary | ovary |
16 | chr12:66464200-66465400 | Enhancers | GM12878-XiMat | blood |
17 | chr12:66464600-66464800 | Enhancers | Monocytes-CD14+_RO01746 | blood |
18 | chr12:66464600-66467000 | Enhancers | Primary monocytes fromperipheralblood | blood |